Expansion Opportunity Pinnacle Clinical Research has recently expanded through the acquisition of Jubilee Clinical Research, signaling a growth trajectory and a broader geographic footprint that includes Las Vegas in addition to its existing New Orleans base. This presents a cross-sell and regional collaboration opportunity for sponsors and CROs seeking wider site networks with multi-therapeutic capabilities.

Therapeutic Focus With specialized expertise in liver disease, metabolic disorders, memory loss, and neurodegenerative conditions, Pinnacle offers targeted enrollment and data quality in high-need areas. This positions sales conversations around complex trial capabilities, site access to diverse patient populations, and accelerated timelines for studies in these therapeutic areas.

Technology Stack Utilization of Power BI, Tableau, NetSuite, and collaboration tools like Asana and monday.com indicates a data-driven, scalable operations model. This can be leveraged to demonstrate robust trial management, real-time reporting, and efficient financial and project oversight to sponsors prioritizing transparency and efficiency.

Growth Readiness Revenue range of 25 to 50 million and a growing national footprint suggest Pinnacle is a mid-market player with the capacity to scale partnerships. Strategic outreach can focus on long-term sponsor relationships, preferred provider arrangements, and multi-site trials that benefit from their expanding network.

Patient-Centric Positioning Emphasis on patient education, cultural sensitivity, and community engagement enhances patient retention and enrollment quality. Sales conversations can highlight this differentiator to sponsors seeking reliable recruitment and high-quality data from diverse populations across multiple sites.